Long-Acting Antiretrovirals and the Cost of HIV Therapies
Carlos del Rio, MD, discusses advances in long-acting antiretrovirals and the costs associated with HIV therapies.
Watch
Peer Engagement for Navigating HIV Care
Representatives from the AIDS Care Group discuss the racial disparities that exist in the HIV/AIDS care continuum for women of color, as well as how a peer engagement and retention program can help.
What to Expect in December's News & Breakthroughs Section of Contagion®
In the December issue of Contagion®, Carlos del Rio, MD, Debra Goff, PharmD, and Paul Sax, MD, discuss the benefit of infectious disease clinicians using Twitter.
Why is it Important to Promote U=U?
Timothy Ray Brown, also known as the "Berlin Patient" discusses why it's important to push out the message that U=U.
Combining EHR and Outreach to Promote Retention in Care
Pamela Gorman, RN, ACRN, discusses how electronic health data and coordinated outreach can be combined to increase retention in care.
Polypharmacy: What Is It and How Does It Impact People Living With HIV
Jennifer Cocohoba, PharmD, summarizes her ANAC 2019 presentation on polypharmacy and how it affects people living with HIV.
Cognitive Training for People With HIV-Associated Neurocognitive Disorder
In an interview at ANAC 2019, Shameka L. Cody, PhD, AGNP-C, discusses the impact of cognitive training on quality of life outcomes for people with HIV-associated neurocognitive disorder.
Importance of Empathy in HIV Treatment
Timothy Ray Brown, formerly known as the “Berlin Patient” explains why it is important for providers to form relationships with patients and avoid stigma and judgment.
The Importance of Including Women in HIV Cure-Related Research
Brian Minalga, MSW, discusses research on the historical exclusion of women in HIV cure-related research.
Challenges of Self-Managing HIV and Diabetes
Julie Zuñiga, PhD, RN, shares findings from her research on self-management of the dual diagnosis of HIV and diabetes.
Timothy Ray Brown: HIV Cure Cheerleader
Timothy Ray Brown is the first person to ever be cured of HIV. He discusses his decision to no longer remain anonymous and why he shares his story with the world.
What is on the Horizon for HIV Prevention?
A new review in The Lancet HIV discusses the next generation of HIV prevention, called PrEP 2.0.
Read More
Traveler's Diarrhea and the Acquisition of Multidrug Resistance
Mark Riddle, MD, DrPH, speaks about his research on travelers’ diarrhea and multidrug resistance at ACG 2019.
Cefiderocol vs High-Dose Meropenem for the Treatment of Patients With Nosocomial Pneumonia
Ryan K. Shields, PharmD, MS, reacts to research presented at IDWeek 2019 on cefiderocol versus high-dose meropenem for patients with nosocomial pneumonia.
HIV Clinic Improvement and Community Engagement
Gregory Felzien, MD, discusses the surprising benefits HIV clinics encounter when they enhance community engagement.
IDWeek 2019 News Network: Assessing Challenges to Treating CABP
Thomas Lodise, PharmD, PhD, provides an overview of options for treating community-acquired bacterial pneumonia and highlights the challenges of the infection.
Community-Based HIV Care Models in Chicago
Max Brito, MD, MPH, discusses his presentation from IDWeek 2019 which compared HIV treatment in a community-based model versus a hospital-based model in Chicago.
HIV Prevention Strategies Beyond PrEP, Catalyzing Clinic Improvement
Gregory Felzien, MD, AAHIVS, discusses prevention beyond PrEP and creating a safe environment for patients with HIV.
Overarching Themes of IDWeek 2019
Erin McCreary, PharmD, BCPS, BCIDP, shares her takeaways from IDWeek 2019.
Assessing NICU Stewardship Needs in South Africa
Pavel Prusakov, PharmD, highlights how he educated pharmacists from South Africa to lead antimicrobial stewardship programs in the NICU with Pablo J. Sánchez, MD, and Debra Goff, PharmD.
What to Expect in October's Editor-in-Chief Letter
Jason Gallagher, PharmD, FCCP, FIDSA, BCPS, editor-in-chief of Contagion®, previews his editor-in-chief letter for the October 2019 issue.
HIV Prevention Strategies in Rural Communities
Gregory Felzien, MD, AAHIVS, discusses barriers to HIV care, particularly in neglected rural areas.
What to Expect in October's Emerging/Re-emerging Infections Section of Contagion®
Hermione Hurley, MD, MCBhB, previews her October cover story for Contagion on the intersection between the opioid epidemic and infectious disease
Implementing the "Train the Trainer" Program in South Africa
Debra Goff, PharmD, shares how the "Train-the-Trainer" program was implemented in South Africa with Pablo J. Sánchez, MD, and Pavel Prusakov, PharmD.
How to Manage Preliminary HIV Positive Results in the ED
Investigators with The University of Texas Health Science Center embarked on a study to determine whether HIV disclosure at the emergency department should be based on preliminary results.
What to Expect in October's Multidrug-Resistant Infections Section of Contagion®
Samuel L. Aitken, PharmD, MPH, discusses the article he wrote with Dr. Sarah L. Spitznogle for the October issue of Contagion® evaluating the role of new β-lactam agents for uncommon pathogens.
What to Expect in October's HIV/AIDS Section of Contagion®
Jason Schafer, PharmD, MPH, BCPS AQ-ID, previews the October issue featuring an article on rapid initiation of antiretroviral therapy.
Why Do We Need NICU Stewardship?
Pablo J. Sánchez, MD, discusses the need for NICU stewardship with Debra Goff, PharmD, and Pavel Prusakov, PharmD.
The Seattle Flu Study: Mapping the Spread of Influenza
Helen Chu, MD, MPH, discussed the "Seattle Flu Study" with Contagion at IDWeek 2019.
What to Expect in October's News and Breakthroughs
Elizabeth Hirsch, PharmD, previews her piece with Mélanie Mahoney, PharmD student, on 2019 updates to CLSI breakpoints.